Search

Your search keyword '"Khan, Muhammad Shahzeb"' showing total 210 results

Search Constraints

Start Over You searched for: Author "Khan, Muhammad Shahzeb" Remove constraint Author: "Khan, Muhammad Shahzeb" Database Complementary Index Remove constraint Database: Complementary Index
210 results on '"Khan, Muhammad Shahzeb"'

Search Results

2. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial.

4. Role of anti‐obesity drugs in heart failure regardless of ejection fraction.

5. GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?

6. Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials.

7. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes.

9. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials

10. Role of telemedicine in the management of obesity: State‐of‐the‐art review.

11. Empagliflozin in the treatment of heart failure.

14. Cardiac wasting and cancer.

17. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.

18. Guideline‐directed medical therapy for heart failure: The key ingredient for successful in‐hospital and post‐discharge care.

19. Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?

20. The effect of sodium–glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta‐analysis.

21. Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial.

22. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis.

23. Creation of next generation of diverse cardiovascular physician–scientists from developing countries: insights from Research Council of Pakistan.

24. Efficient electrocatalytic oxygen evolution by nano NiO-In2O3 electrode materials.

25. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.

26. Endpoint adjudication in cardiovascular clinical trials.

27. Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.

28. Association of diabetes‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study.

31. Artificial intelligence and heart failure: A state‐of‐the‐art review.

32. The Interplay between Online Consumer Reviews and Firms Interventions from Four Stakeholders' Perspectives.

33. Kidney involvement in transthyretin cardiac amyloidosis – Role of urinary albumin to creatinine ratio and need for further evidence generation.

34. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta‐analysis.

35. Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.

37. Ni-Doped In 2 O 3 Nanoparticles and Their Composite with rGO for Efficient Degradation of Organic Pollutants in Wastewater under Visible Light Irradiation.

38. Vericiguat for the treatment of heart failure with reduced ejection fraction.

39. Recent advancements in molecularly imprinted polymers for the removal of heavy metal ions and dyes.

40. Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum.

41. Designing of Un-Fused Electron Acceptors with Enhanced Power Conversion Efficiency by Introducing Unique S–O Noncovalent Interaction.

42. Pressures do not equal volumes: implications for heart failure management in patients with CardioMEMS.

45. Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced.

46. Current status of global research on pericardial diseases: a bibliometric analysis of the top 100 from Web of Science.

47. Mechanisms of current therapeutic strategies for heart failure: more questions than answers?

48. Advanced Photoelectrochemical Hydrogen Generation by CdO-g-C 3 N 4 in Aqueous Medium under Visible Light.

49. Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes—Findings from the Look AHEAD Trial.

50. Safety and feasibility of same-day discharge for catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources